Ren Hong Tang
Director/Board Member bij SIMCERE PHARMACEUTICAL GROUP LIMITED
Vermogen: 2 M $ op 31-03-2024
Profiel
Ren Hong Tang is currently an Executive Director at Simcere Pharmaceutical Group Ltd.
and an Executive Director at Jiangsu Simcere Pharmaceutical Co., Ltd.
Previously, he held positions as the Chairman & General Manager at Jiangsu Simcere Medical Diagnostics Co., Ltd., Associate Director-China Innovation Center at AstraZeneca Investment (China) Co. Ltd., Director at 3D Medicines, Inc., and Vice General Manager at Shanghai Shengdi Pharmaceutical Co., Ltd.
He obtained a doctorate degree from Nanyang Technological University in 2007 and an undergraduate degree from Shanghai Jiao Tong University in 2002.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-11-2023 | 3 650 000 ( 0.14% ) | 2 M $ | 31-03-2024 |
Actieve functies van Ren Hong Tang
| Bedrijven | Functie | Begin |
|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Director/Board Member | 01-11-2019 |
Jiangsu Simcere Pharmaceutical Co., Ltd.
 Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The private company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Director/Board Member | - |
Eerdere bekende functies van Ren Hong Tang
| Bedrijven | Functie | Einde |
|---|---|---|
| Shanghai Shengdi Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01-05-2019 |
| AstraZeneca Investment (China) Co. Ltd. | Corporate Officer/Principal | 01-08-2017 |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
 Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Chief Executive Officer | - |
| 3D MEDICINES INC. | Director/Board Member | - |
Opleiding van Ren Hong Tang
| Nanyang Technological University | Doctorate Degree |
| Shanghai Jiao Tong University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| 3D MEDICINES INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The private company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Health Technology |
| AstraZeneca Investment (China) Co. Ltd. | |
| Shanghai Shengdi Pharmaceutical Co., Ltd. | |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Health Technology |
